연구정보
[경제] Financing research and development for new vaccines in Asia-Pacific developing countries
동남아시아 일반 국외연구자료 연구보고서 - UNESCAP 발간일 : 2022-11-23 등록일 : 2022-12-04 원문링크
There have been many important innovations in the landscape of vaccine development for neglected and emerging infectious diseases, such as the launch of public-private product development partnerships (PDPs). However, there is still a gap in funding the development of such vaccines, especially when it comes to financing late-stage trials. There is a financial risk in investing in late-stage trials, and there is no guarantee of a commercial market, particularly for the most neglected diseases of poverty. One result of the funding gap is that there are many infectious diseases with a high burden in the Asia-Pacific region for which there are no licensed, highly effective vaccines, including HIV/AIDS, tuberculosis, soil-transmitted helminths and schistosomiasis. There are also neglected infectious diseases that affect populations in the region where the existing vaccines have limitations, such as malaria, dengue, and Japanese encephalitis.
본 페이지에 등재된 자료는 운영기관(KIEP) 및 EMERiCs의 공식적인 입장을 대변하고 있지 않습니다.
| 이전글 | [경제] Asia-Pacific sustainable development journal. Vol. 29, No. 2, November 2022 | 2022-12-04 |
|---|---|---|
| 다음글 | [경제] ICMA-ASIFMA Asia Pacific Repo Survey | 2022-12-08 |
